Table 3.
State | Pneumococcal vaccine coverage | ||
---|---|---|---|
Work-related asthma, %a (95% CI) | Possible work-related asthma, %a (95% CI) | Non-work-related asthma, %a (95% CI) | |
California | 51.5 (31.9, 71.0) | 43.7 (31.4, 55.9) | 31.2 (21.1, 41.3) |
Connecticut | – | 34.2 (16.0, 52.5) | 26.9 (13.9, 39.9) |
Georgia | – | – | – |
Hawaii | – | 36.4 (22.5, 50.4) | 38.5 (24.0, 52.9) |
Illinois | – | 56.9 (38.9, 75.0) | – |
Indiana | 61.5 (48.1, 74.8) | 41.0 (32.3, 49.7) | 32.2 (23.3, 41.0) |
Iowa | – | 51.6 (39.2, 64.1) | 46.8 (34.2, 59.4) |
Maryland | – | 45.7 (26.7, 64.6) | 41.2 (25.1, 57.2) |
Michigan | 47.3 (33.9, 60.7) | 39.0 (31.9, 46.1) | 44.1 (36.3, 51.9) |
Mississippi | 60.9 (44.0, 77.8) | 36.8 (26.4, 47.1) | 37.4 (21.8, 52.9) |
Missouri | 61.9 (44.4, 79.3) | 43.0 (30.4, 55.6) | 46.4 (31.1, 61.7) |
Montana | 59.4 (43.6, 75.2) | 30.5 (20.6, 40.5) | 45.5 (33.4, 57.5) |
Nebraska | 45.7 (33.2, 58.1) | 41.0 (32.0, 49.9) | 39.4 (29.8, 48.9) |
Nevada | – | 35.2 (18.5, 52.0) | 42.5 (22.1, 63.0) |
New Hampshire | 56.0 (36.3, 75.7) | 46.6 (35.3, 57.9) | 28.4 (17.3, 39.5) |
New Jersey | – | 31.4 (15.4, 47.4) | 36.1 (22.2, 50.1) |
New Mexico | 53.1 (33.6, 72.6) | 43.3 (32.5, 54.1) | 27.4 (19.2, 35.6) |
New York | – | 42.2 (26.4, 58.0) | 35.5 (21.1, 49.8) |
North Carolina | – | – | – |
Ohio | 66.8 (49.2, 84.3) | 47.5 (34.6, 60.4) | 35.5 (25.7, 45.3) |
Oklahoma | 62.5 (44.3, 80.8) | 44.4 (33.1, 55.6) | 40.8 (27.1, 54.5) |
Oregon | – | 48.4 (34.0, 62.8) | 32.5 (20.1, 44.8) |
Pennsylvania | 55.7 (42.9, 68.5) | 47.4 (38.2, 56.6) | 40.3 (31.2, 49.5) |
Texas | 64.4 (46.4, 82.4) | 41.2 (29.6, 52.9) | – |
Utah | – | 47.4 (34.7, 60.1) | 38.4 (26.8, 49.9) |
Vermont | – | 44.3 (32.5, 56.1) | 27.1 (16.3, 37.9) |
Washington | 47.9 (33.1, 62.6) | 45.5 (35.8, 55.1) | 36.6 (27.8, 45.4) |
West Virginia | – | 44.8 (29.6, 60.1) | – |
Wisconsin | 55.7 (37.7, 73.7) | 41.3 (25.5, 57.1) | 46.6 (34.4, 58.9) |
Weighted average annual estimate.
“–” indicates relative SE >30% or sample denominator <50 respondents, estimate not reportable.